EMA/HMA – The European Medicines Agencies Network Data Strategy – Increasing the value of data for the benefit of public and animal health
The EMA recently published the European medicines regulatory network Data Strategy – Increasing the value of data for the benefit of public and animal health.
This strategy sets out the agreed European medicines regulatory network (EMRN) vision, principles to be followed and goals to be met to maximize the value of the data managed by the EMRN. Getting the full value from data requires the data to be of good quality, well documented, and accessible for consumers of the data. This strategy is to guide the network and to inform stakeholders of the activities that the network will be undertaking to realise its vision for data.
The strategy is set in the overall context of general EU requirements for data protection (EUDPR, GDPR), data sharing and interoperability (EU Data Act, EU Interoperability Act) as well as domain specific initiatives like the European Health Data Space (EHDS) and it is closely linked to business strategies such as the overarching European medicines agencies network strategy to 2028
More information on the EU network data strategy on the EMA website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (11 décembre 2025). EMA/HMA – The European Medicines Agencies Network Data Strategy – Increasing the value of data for the benefit of public and animal health. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/15buk





